The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts.
Journal
Research square
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035
Informations de publication
Date de publication:
14 Apr 2023
14 Apr 2023
Historique:
pubmed:
24
4
2023
medline:
24
4
2023
entrez:
24
04
2023
Statut:
epublish
Résumé
Among the most common genetic alterations in the myelodysplastic syndromes (MDS) are mutations in the spliceosome gene
Identifiants
pubmed: 37090662
doi: 10.21203/rs.3.rs-2802265/v1
pmc: PMC10120771
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL159306
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM118136
Pays : United States
Organisme : NHLBI NIH HHS
ID : R56 HL159306
Pays : United States
Déclaration de conflit d'intérêts
Competing Interests The authors declare no competing interests.
Références
Nature. 2019 Oct;574(7778):432-436
pubmed: 31597964
Sci Transl Med. 2023 Mar;15(685):eabn5135
pubmed: 36857430
Nature. 2011 Sep 11;478(7367):64-9
pubmed: 21909114
Blood. 2022 Aug 25;140(8):875-888
pubmed: 35709354
Mol Cell. 2016 Oct 20;64(2):307-319
pubmed: 27720643
Blood. 2011 Dec 22;118(26):6904-8
pubmed: 22039264
J Clin Oncol. 2021 Nov 20;39(33):3737-3746
pubmed: 34406850
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Mol Cell. 2018 Feb 1;69(3):412-425.e6
pubmed: 29395063
Cancer Cell. 2015 May 11;27(5):617-30
pubmed: 25965569
Leukemia. 2022 Jul;36(7):1703-1719
pubmed: 35732831
Cancer Discov. 2017 Aug;7(8):818-831
pubmed: 28572459
Nat Commun. 2022 Oct 1;13(1):5773
pubmed: 36182931
Br J Haematol. 2015 Nov;171(4):478-90
pubmed: 26255870
Lancet Oncol. 2017 Oct;18(10):1338-1347
pubmed: 28870615
Leukemia. 2021 Apr;35(4):1108-1120
pubmed: 32753690
Nat Commun. 2018 Sep 7;9(1):3649
pubmed: 30194306
J Clin Oncol. 2022 Nov 20;40(33):3800-3807
pubmed: 35998303
N Engl J Med. 2011 Oct 13;365(15):1384-95
pubmed: 21995386
Proc Natl Acad Sci U S A. 2015 Aug 25;112(34):E4726-34
pubmed: 26261309
Blood. 2022 Mar 31;139(13):2038-2049
pubmed: 34861039
Mol Cell. 2019 Oct 3;76(1):82-95.e7
pubmed: 31474574
Blood Adv. 2021 Mar 9;5(5):1565-1575
pubmed: 33687432
Nat Biotechnol. 2022 Jul;40(7):1103-1113
pubmed: 35241838
Cell Rep. 2015 Nov 3;13(5):1033-45
pubmed: 26565915
Cell Rep. 2018 Apr 3;23(1):282-296.e4
pubmed: 29617667
Blood. 2020 Jul 9;136(2):157-170
pubmed: 32347921
Nat Med. 2016 Jun;22(6):672-8
pubmed: 27135740
Nat Genet. 2013 Feb;45(2):133-5
pubmed: 23313955
Blood. 2020 Sep 24;136(13):1477-1486
pubmed: 32640014
J Clin Oncol. 2021 Apr 10;39(11):1223-1233
pubmed: 33539200
Blood. 2011 Dec 8;118(24):6239-46
pubmed: 21998214
Blood. 2020 Dec 17;136(25):2893-2904
pubmed: 32614947
Blood. 2018 Sep 20;132(12):1225-1240
pubmed: 29930011
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
J Clin Invest. 2019 Aug 8;129(11):4708-4723
pubmed: 31393856
Leukemia. 2014 Feb;28(2):241-7
pubmed: 24220272
Elife. 2022 Aug 30;11:
pubmed: 36040792
N Engl J Med. 2020 Jan 9;382(2):140-151
pubmed: 31914241
Nat Commun. 2020 Jan 9;11(1):137
pubmed: 31919425
Nat Commun. 2015 Jan 14;6:6042
pubmed: 25586593
Sci Transl Med. 2019 Jul 10;11(500):
pubmed: 31292266
Comput Struct Biotechnol J. 2021 Feb 27;19:1361-1370
pubmed: 33777335
Nucleic Acids Res. 2017 May 5;45(8):4837-4852
pubmed: 28062854
Cancer Cell. 2018 Aug 13;34(2):225-241.e8
pubmed: 30107174
Am J Hematol. 2022 Jun 1;97(6):E210-E214
pubmed: 35293000
Genome Res. 2015 Jan;25(1):14-26
pubmed: 25267526
Cancer Discov. 2020 Jun;10(6):806-821
pubmed: 32188705
Blood Adv. 2020 Apr 14;4(7):1192-1196
pubmed: 32211880
Blood. 2022 Sep 15;140(11):1200-1228
pubmed: 35767897